Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer

Introduction: Fatty liver disease is characterized by deposition of fat droplets in the liver of patients. According to some epidemiological studies; BMI, amount of fat intake from foods and high central fat are risk factors of breast cancer. This issue is one of the factors that cause high incidenc...

Full description

Bibliographic Details
Main Authors: Sh Keyhanian, AH Ghoreishi, Z Fotoukian, M Omrani-nava, F Jassemi-zergani, MM Saravi
Format: Article
Language:fas
Published: Shahid Sadoughi University of Medical Sciences 2013-08-01
Series:Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
Subjects:
Online Access:http://jssu.ssu.ac.ir/browse.php?a_code=A-10-519-6&slc_lang=en&sid=1
_version_ 1818566236310601728
author Sh Keyhanian
AH Ghoreishi
Z Fotoukian
M Omrani-nava
F Jassemi-zergani
MM Saravi
author_facet Sh Keyhanian
AH Ghoreishi
Z Fotoukian
M Omrani-nava
F Jassemi-zergani
MM Saravi
author_sort Sh Keyhanian
collection DOAJ
description Introduction: Fatty liver disease is characterized by deposition of fat droplets in the liver of patients. According to some epidemiological studies; BMI, amount of fat intake from foods and high central fat are risk factors of breast cancer. This issue is one of the factors that cause high incidence of fatty liver in patients with breast cancer. Methods: In this cross-sectional descriptive study, all patients with breast cancer were evaluated who referred to Imam Sajjad hospital of Ramsar during 2008 - 2011. After initial review, 100 patients were enrolled. Those who were treated by chemotherapy underwent abdominal Sonography for evaluation of fatty liver. Also, those patients who also received tamoxifen in addition to chemotherapy, underwent abdominal ultrasonography 6 months after taking tamoxifen. After that, relationship between treatment of breast cancer and fatty liver in studied patients was evaluated based on obtained information. Results: The study results revealed that after chemotherapy, 30 (30%) patients were reported to have fatty liver. Out of 70 people that after chemotherapy did not have fatty liver, 62 patients received tamoxifen; and after taking tamoxifen, 45.2% developed fatty liver. Using Chi Square test, there was a significant relationship between fatty liver after receiving tamoxifen, hyperlipidemia (p=0.011) and getting overweight (P =0.017). Conclusion: As the findings indicated, treatment of breast cancer especially with tamoxifen is associated with increased risk of fatty liver, especially in women who have hyperlipidemia and are overweight.
first_indexed 2024-12-14T01:51:10Z
format Article
id doaj.art-937c12104b274b6f9973c53ef35f11f9
institution Directory Open Access Journal
issn 2228-5741
2228-5733
language fas
last_indexed 2024-12-14T01:51:10Z
publishDate 2013-08-01
publisher Shahid Sadoughi University of Medical Sciences
record_format Article
series Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
spelling doaj.art-937c12104b274b6f9973c53ef35f11f92022-12-21T23:21:23ZfasShahid Sadoughi University of Medical SciencesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd2228-57412228-57332013-08-01213271280Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast CancerSh KeyhanianAH GhoreishiZ FotoukianM Omrani-navaF Jassemi-zerganiMM SaraviIntroduction: Fatty liver disease is characterized by deposition of fat droplets in the liver of patients. According to some epidemiological studies; BMI, amount of fat intake from foods and high central fat are risk factors of breast cancer. This issue is one of the factors that cause high incidence of fatty liver in patients with breast cancer. Methods: In this cross-sectional descriptive study, all patients with breast cancer were evaluated who referred to Imam Sajjad hospital of Ramsar during 2008 - 2011. After initial review, 100 patients were enrolled. Those who were treated by chemotherapy underwent abdominal Sonography for evaluation of fatty liver. Also, those patients who also received tamoxifen in addition to chemotherapy, underwent abdominal ultrasonography 6 months after taking tamoxifen. After that, relationship between treatment of breast cancer and fatty liver in studied patients was evaluated based on obtained information. Results: The study results revealed that after chemotherapy, 30 (30%) patients were reported to have fatty liver. Out of 70 people that after chemotherapy did not have fatty liver, 62 patients received tamoxifen; and after taking tamoxifen, 45.2% developed fatty liver. Using Chi Square test, there was a significant relationship between fatty liver after receiving tamoxifen, hyperlipidemia (p=0.011) and getting overweight (P =0.017). Conclusion: As the findings indicated, treatment of breast cancer especially with tamoxifen is associated with increased risk of fatty liver, especially in women who have hyperlipidemia and are overweight.http://jssu.ssu.ac.ir/browse.php?a_code=A-10-519-6&slc_lang=en&sid=1Breast cancer; Chemotherapy; Fatty Liver; Tamoxifen
spellingShingle Sh Keyhanian
AH Ghoreishi
Z Fotoukian
M Omrani-nava
F Jassemi-zergani
MM Saravi
Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
Majallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd
Breast cancer; Chemotherapy; Fatty Liver; Tamoxifen
title Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
title_full Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
title_fullStr Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
title_full_unstemmed Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
title_short Relationship between Chemotherapy and Tamoxifen with Incidence of Fatty Liver in Women with Breast Cancer
title_sort relationship between chemotherapy and tamoxifen with incidence of fatty liver in women with breast cancer
topic Breast cancer; Chemotherapy; Fatty Liver; Tamoxifen
url http://jssu.ssu.ac.ir/browse.php?a_code=A-10-519-6&slc_lang=en&sid=1
work_keys_str_mv AT shkeyhanian relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer
AT ahghoreishi relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer
AT zfotoukian relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer
AT momraninava relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer
AT fjassemizergani relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer
AT mmsaravi relationshipbetweenchemotherapyandtamoxifenwithincidenceoffattyliverinwomenwithbreastcancer